To determine whether seizures may worsen indications of tau spread in AD, we analyzed postmortem pathological ratings across 18 different brain regions from AD patients and stratified subjects based on the presence or absence of clinical seizure history. The gene discussed is MAPT; the disease is Alzheimer disease.